We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
21 hedge funds and large institutions have $2.15M invested in CASI Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
6.78% less ownership
Funds ownership: 13.76% → 6.98% (-6.8%)
13% less funds holding
Funds holding: 24 → 21 (-3)
35% less capital invested
Capital invested by funds: $3.29M → $2.15M (-$1.13M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$9.15K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$8.15K |
| 3 |
Renaissance Technologies
New York
|
+$4.24K |
| 4 |
Franklin Resources
San Mateo,
California
|
+$726 |
